Rhythm Pharmaceuticals Inc
SWB:1RV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rhythm Pharmaceuticals Inc
SWB:1RV
|
US |
|
S
|
Shaftesbury Capital PLC
OTC:CCPPF
|
UK |
|
Neurotech International Ltd
ASX:NTI
|
AU |
|
E
|
Ege Profil Ticaret ve Sanayi AS
IST:EGPRO.E
|
TR |
|
Euro Yatirim Holding AS
IST:EUHOL.E
|
TR |
|
P
|
Palantir Technologies Inc
F:PTX
|
US |
|
N
|
Nomura Research Institute Ltd
XMUN:NR7
|
JP |
|
A
|
Autodesk Inc
DUS:AUD
|
US |
|
P
|
Platinum Group Metals Ltd
F:P6MB
|
CA |
|
O
|
Oceaneering International Inc
LSE:0KAN
|
US |
|
N
|
NetApp Inc
F:NTA
|
US |
|
Ryan Specialty Holdings Inc
NYSE:RYAN
|
US |
|
T
|
Thua Thien Hue Construction Joint Stock Corp
VN:HUB
|
VN |
|
F
|
Fluence Corporation Ltd
F:4SVE
|
US |
|
Tourism Holdings Ltd
F:UCH
|
NZ |
|
T
|
Thermo Fisher Scientific Inc
XMUN:TN8
|
US |
Intrinsic Value
Is 1RV undervalued or overvalued?
See the intrinsic value estimate for 
Rhythm Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Rhythm Pharmaceuticals Does
Rhythm Pharmaceuticals is a biopharmaceutical company that focuses on rare genetic diseases that cause severe obesity. Its main product is Imcivree, a prescription medicine used for certain patients whose body’s appetite-control pathway does not work properly. The company also develops follow-on treatments aimed at the same biology, especially the melanocortin-4 receptor pathway that helps regulate hunger and body weight.
- Headquarters
- United States of America US
- Employees
- 414
- IPO date
- Oct 5, 2017
Revenue & Expenses Breakdown
Rhythm Pharmaceuticals Inc
Earnings Waterfall
Rhythm Pharmaceuticals Inc
The intrinsic value for Rhythm Pharmaceuticals Inc (1RV) under the Base Case is hidden EUR.
Compared with the current market price of 92 EUR, the stock appears hidden.
